论文部分内容阅读
研究对象为2015年8月至2017年3月期间收治的80例高血压合并高血脂患者,随机分为对照组与观察组各40例,对照组运用氨氯地平治疗,观察组运用氨氯地平联合瑞舒伐他汀治疗,分析两组患者治疗后血脂与血压等治疗效果差异,探讨高血压合并高血脂采用瑞舒伐他汀治疗的效果。结果表明,高血压合并高血脂采用瑞舒伐他汀治疗可以有效的提升治疗疗效,改善疾病相关危险指标,效果显著。
The subjects were 80 patients with hypertension and hyperlipemia admitted from August 2015 to March 2017. They were randomly divided into control group and observation group of 40 cases each. The control group was treated with amlodipine. The observation group was treated with amlodipine Combined with rosuvastatin treatment, analysis of two groups of patients after treatment of blood lipids and blood pressure and other differences in the treatment effect of hypertension with hyperlipidemia with rosuvastatin treatment effect. The results showed that hypertension combined with hyperlipidemia treated with rosuvastatin can effectively improve the therapeutic effect and improve the disease-related risk indicators, the effect is significant.